Literature DB >> 33862031

Losing balance: Kainate receptors and psychiatric disorders comorbidities.

Sergio Valbuena1, Juan Lerma2.   

Abstract

Cognition and behavior are tightly linked to synaptic function. A growing body of evidence suggests that aberrant neurotransmission, caused by changes in synaptic protein expression levels, may be a major cause underlying different brain disorders. These changes in expression result in abnormal synaptic organization or function, leading to impaired neurotransmission and unbalanced circuit operations. Here, we review the data supporting the involvement of mutations in genes coding for kainate receptor (KAR) subunits in the pathogenesis of psychiatric disorders and Down syndrome (DS). We show that most of these mutations do not affect the biophysical properties or the receptors, but rather alter subunit expression levels. On the basis of reports studying KAR genes mutations in mouse models of autism spectrum disorders and DS, we illustrate how deviations from the physiological regulatory role that these receptors play in neurotransmitter release and plasticity give rise to synaptic alterations that lead to behavioral and cognitive deficits underlying these disorders.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Autism; Depression; Down syndrome; GABA; Glutamate; Neurotransmitter release; Protein dosage; Spatial memory; Synapse

Mesh:

Substances:

Year:  2021        PMID: 33862031     DOI: 10.1016/j.neuropharm.2021.108558

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  2 in total

Review 1.  Structure, Function, and Regulation of the Kainate Receptor.

Authors:  Surbhi Dhingra; Juhi Yadav; Janesh Kumar
Journal:  Subcell Biochem       Date:  2022

2.  Discovery of the First Highly Selective Antagonist of the GluK3 Kainate Receptor Subtype.

Authors:  Paulina Chałupnik; Alina Vialko; Darryl S Pickering; Markus Hinkkanen; Stephanie Donbosco; Thor C Møller; Anders A Jensen; Birgitte Nielsen; Yasmin Bay; Anders S Kristensen; Tommy N Johansen; Kamil Łątka; Marek Bajda; Ewa Szymańska
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.